- Discrepant Results for BRAF V600E Mutation Among Different Specimens in a Case of Hairy Cell Leukemia
-
Moon HW, Hur M, Han SH, Yun YM, Kim SY
- KMID: 1707241
- Ann Lab Med.
- 2013 Jul;33(4):300-303.
- doi: 10.3343/alm.2013.33.4.300
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- BRAF V600E and MAP2K1 Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma Cases
-
Shin SY, Lee ST, Kim HJ, Ki CS, Jung CW, Kim JW, Kim SH
- KMID: 2363190
- Ann Lab Med.
- 2015 Mar;35(2):257-259.
- doi: 10.3343/alm.2015.35.2.257
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Correlation of Immunohistochemical Markers and BRAF Mutation Status with Histological Variants of Papillary Thyroid Carcinoma in the Korean Population
-
Min HS, Lee C, Jung KC
- KMID: 1786960
- J Korean Med Sci.
- 2013 Apr;28(4):534-541.
- doi: 10.3346/jkms.2013.28.4.534
Several pathologic characteristics are associated with an adverse clinical outcome in papillary thyroid carcinoma (PTC), including the histological variant. This study aimed to investigate immunohistochemical expression and BRAF mutation status... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinicopathological Features of Rare BRAF Mutations in Korean Thyroid Cancer Patients
-
Cho U, Oh WJ, Bae JS, Lee S, Lee YS, Park GS, Lee YS, Jung CK
- KMID: 2129598
- J Korean Med Sci.
- 2014 Aug;29(8):1054-1060.
- doi: 10.3346/jkms.2014.29.8.1054
The most common BRAF mutation in thyroid cancer is c.1799T>A (p.Val600Glu), and other BRAF mutations are rarely reported. We investigated the clinicopathological features of thyroid cancer with rare BRAF mutations.... -
- CITED
-
- Close
- SHARE
-
- Close
- B-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1
-
Choi YW, Kim HJ, Kim YH, Park SH, Chwae YJ, Lee J, Soh EY, Kim JH, Park TJ
- KMID: 2155385
- Exp Mol Med.
- 2014 Nov;46(11):e120.
- doi: 10.1038/emm.2014.68
B-RafV600E mutant is found in 40-70% of papillary thyroid carcinoma (PTC) and has an important role in the pathogenesis of PTC. The sodium iodide symporter (NIS) is an integral plasma... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the Anyplex BRAF V600E Real-Time Detection Assay Using Dual-Priming Oligonucleotide Technology in Fine-Needle Aspirates of Thyroid Nodules
-
Choi R, Park KS, Kim JW, Ki CS
- KMID: 2363266
- Ann Lab Med.
- 2015 Nov;35(6):624-629.
- doi: 10.3343/alm.2015.35.6.624
BACKGROUND: Several molecular assays have been developed to detect the BRAF V600E mutation in fine needle aspirates (FNAs) for the diagnosis of papillary thyroid cancer. Using a multiplex PCR technique,... -
- CITED
-
- Close
- SHARE
-
- Close
- Detection of Plasma BRAF(V600E) Mutation Is Associated with Lung Metastasis in Papillary Thyroid Carcinomas
-
Kim BH, Kim IJ, Lee BJ, Lee JC, Kim IS, Kim SJ, Kim WJ, Jeon YK, Kim SS, Kim YK
- KMID: 2450335
- Yonsei Med J.
- 2015 May;56(3):634-640.
- doi: 10.3349/ymj.2015.56.3.634
PURPOSE: The BRAF(V600E) mutation represents a novel indicator of the progression and aggressiveness of papillary thyroid carcinoma (PTC). The purpose of this study was to determine the clinical significance of... -
- CITED
-
- Close
- SHARE
-
- Close
- Mutational Analysis of KRAS, BRAF, and TP53 Genes of Ovarian Serous Carcinomas in Korean Women
-
Cho YH, Kim DY, Kim JH, Kim YM, Kim KR, Nam JH, Kim YT
- KMID: 2396071
- Yonsei Med J.
- 2009 Apr;50(2):266-272.
PURPOSE: To assess the prevalence of KRAS, BRAF, and TP53 mutations in cases of low-grade and high-grade serous carcinomas and to evaluate the clinical outcomes of these morphologically distinct carcinomas.... -
- CITED
-
- Close
- SHARE
-
- Close
- Mutations of the BRAF Gene in Papillary Thyroid Carcinoma in a Korean Population
-
Kim KH, Kang DW, Kim SH, Seong IO, Kang DY
- KMID: 1103903
- Yonsei Med J.
- 2004 Oct;45(5):818-821.
- doi: 10.3349/ymj.2004.45.5.818
The B-type Raf kinase (BRAF) protein is a serine/threonine kinase that has an important role in cellular proliferation, differentiation, and programmed cell death. The BRAF gene has been recently found... -
- CITED
-
- Close
- SHARE
-
- Close
- Can Ultrasound Be as a Surrogate Marker for Diagnosing a Papillary Thyroid Cancer? Comparison with BRAF Mutation Analysis
-
Seo JY, Kim EK, Baek JH, Shin JH, Han KH, Kwak JY
- KMID: 2130809
- Yonsei Med J.
- 2014 Jul;55(4):871-878.
- doi: 10.3349/ymj.2014.55.4.871
PURPOSE: We investigated the merit of ultrasound (US) features and BRAF(V600E) mutation as an additional study of cytology and compared the diagnostic performances of cytology alone, cytology with US correlation,... -
- CITED
-
- Close
- SHARE
-
- Close
- Identification of a Rare 3 bp BRAF Gene Deletion in a Thyroid Nodule by Mutant Enrichment with 3'-Modified Oligonucleotides Polymerase Chain Reaction
-
Jang MA, Lee ST, Oh YL, Kim SW, Chung JH, Ki CS, Kim JW
- KMID: 1381693
- Ann Lab Med.
- 2012 May;32(3):238-241.
- doi: 10.3343/alm.2012.32.3.238
Papillary thyroid carcinoma (PTC) is the most common malignant thyroid tumor, and 36-69% of PTC cases are caused by mutations in the BRAF gene. The substitution of a valine for... -
- CITED
-
- Close
- SHARE
-
- Close
- Microarray Analysis of Papillary Thyroid Cancers in Korean
-
Kim HS, Kim DH, Kim JY, Jeoung NH, Lee IK, Bong JG, Jung ED
- KMID: 964721
- Korean J Intern Med.
- 2010 Dec;25(4):399-407.
- doi: 10.3904/kjim.2010.25.4.399
BACKGROUND/AIMS: Papillary thyroid cancer (PTC) is the most common malignancy of the thyroid gland. It involves several molecular mechanisms. The BRAF V600E mutation has been identified as the most common... -
- CITED
-
- Close
- SHARE
-
- Close
